Document:

PERSONAL SERVICES AGREEMENT

         This Personal Services Agreement (the "Agreement") is entered into this
31st day of May, 2004 by and between CytoDyn,  Inc., a Colorado corporation (the
"Company") with its principal place of business at 200 W. DeVargas Street, Suite
1, Santa Fe, New Mexico 87501, and Corinne Allen an individual residing at 24 W.
Sunlit  Drive,  Santa Fe, NM 87508  ("Executive")  to be effective as of May 31,
2004 (the "Effective Date").

                                    PREMISES
                                    --------

         WHEREAS,  the Company desires to employ Executive pursuant to the terms
and  conditions  and for the  consideration  set  forth  in this  Agreement  and
Executive  desires to enter the employ of the Company pursuant to such terms and
conditions and for such consideration;

         WHEREAS,  the provisions of this Agreement are a condition of Executive
being  employed by the Company,  of  Executive's  having access to  confidential
business and  technological  information,  and of Executive's  being eligible to
receive certain benefits of the Company.  This Agreement is entered into, and is
reasonably   necessary,   to  protect  confidential   information  and  customer
relationships  to which  Executive may have access,  and to protect the goodwill
and other business interests of the Company; and

         WHEREAS,  the  provisions  of this  Agreement  are also a condition  to
Executive's agreement to provide personal services to the Company.

         NOW THEREFORE,  in  consideration  of the mutual promises and covenants
agreed to herein, the receipt and sufficiency of which are hereby  acknowledged,
the Company and Executive agree as follows:

                                    AGREEMENT
                                    ---------

         1.       Position, Term, Duties, Responsibilities.

                  (a)      Position.  Executive shall be employed by the Company
         as its Vice President of Business Development to act in accordance with
         the terms and conditions hereinafter set forth.

                  (b)      Duties.  Executive  shall  faithfully  and diligently
         render   such   services   and   perform   such   related   duties  and
         responsibilities as are customarily  performed by a person holding such
         title and as otherwise  may, from time to time, be reasonably  assigned
         to  Executive  by the  Company's  Chief  Executive  Officer  and/or the
         Company's Board of Directors (the "Board"). Executive shall comply with
         the provisions of this Agreement and all reasonable rules,  regulations
         and  administrative  directions  now or  hereafter  established  by the
         Company.

                  (c)      Term. This Agreement shall be for a term beginning on
         the Effective Date and terminating the earlier of (i) the date which is
         24 months from the Effective Date (the "Expiration  Date"), or (ii) the
         date on which Executive's  employment is terminated pursuant to Section
         3 (collectively, the "Term").

<PAGE>

                  (d)      Proprietary Information. Executive agrees to sign and
         to be  bound  by and  comply  with  the  terms  and  conditions  of the
         Company's Employee  Proprietary  Information and Inventions  Agreement,
         which  is  attached  to  this   Agreement   as  Exhibit  A  and  hereby
         incorporated into and deemed a part of this Agreement.

         2.       Compensation, Bonuses and Benefits.

                  (a)      Base Salary.  During Executive's  employment with the
         Company,  the Company  shall pay  Executive  a base annual  salary (the
         "Base Salary") of Fifty  Thousand  Dollars  ($50,000).  The Base Salary
         shall be  payable  in  accordance  with the  Company's  normal  payroll
         schedule,  less all applicable tax  withholdings  for state and federal
         income  taxes,  FICA and other  deductions  as  required  by law and/or
         authorized by  Executive.  If the Base Salary is increased or decreased
         during the Term then the base salary of  Executive  as so  increased or
         decreased shall constitute the Base Salary of Executive for purposes of
         this  Agreement  from and after the effective  date of such increase or
         decrease.

                  (b)      Incentive  Compensation  Program.  During Executive's
         employment with the Company, Executive shall be entitled to participate
         in  such  incentive  compensation  programs  as are  from  time to time
         established  and approved by the Board in accordance with the Company's
         practice for similarly situated employees.

                  (c)      Benefits.  Executive shall be entitled to participate
         in such  employee  benefit  plans  which the  Company  provides  or may
         establish  from time to time for the benefit of  employees,  subject to
         the terms of each such plan and subject to the right of the Company and
         the Board to modify,  revise or eliminate  such benefit plans from time
         to time in their sole  discretion.  Executive shall pay for the portion
         of the cost of such benefits as is established from time-to-time by the
         Company as the portion of such cost to be paid by senior  executives of
         the Company.

                  (d)      Costs and  Expenses.  Executive  shall be entitled to
         reimbursement  for  all  ordinary  reasonable   out-of-pocket  business
         expenses that are  reasonably  incurred by Executive in  furtherance of
         the Company's  business,  in accordance with the policies  adopted from
         time to time by the  Company or the Board.  Executive  will comply with
         the Company's  travel policies as established  from time to time by the
         Company or the Board.

                  (e)      Vacation.  Executive  shall be entitled to  vacations
         with  pay in  accordance  with the  Company's  practice  for  similarly
         situated  employees.  Executive  will use his best  efforts to schedule
         vacation periods to minimize disruption of the Company's business.

         3.       Termination.

                  (a)      Mutual Agreement.  Executive's  employment under this
         Agreement may be terminated at any time by the mutual written agreement
         of the Company and Executive.

                  (b)      Voluntary.    Executive's   employment   under   this
         Agreement may be terminated by Executive with or without the consent of
         the Company by giving written notice of termination at least four weeks
         prior to the effective date of such termination.  After receipt of such

                                       2
<PAGE>

         notice the Company may accelerate the date that such  termination  will
         take effect  pursuant to this Section  3(b) without  being in breach of
         this Agreement.

                  (c)      Without Cause. The Company may terminate  Executive's
         employment  under this  Agreement at any time without  Cause  effective
         immediately upon written notice to Executive.

                  (d)      Disability  or  Death.   The  Company  may  terminate
         Executive's   employment   under  this  Agreement  upon  the  death  or
         disability  of  Executive.  Subject  to  Executive's  rights  under any
         applicable  law,   including  the  Americans  with   Disabilities  Act,
         Executive  shall be  considered  disabled if (i) Executive is unable to
         perform his duties under this Agreement as a result of injury,  illness
         or other  disability  for a period of 180  consecutive  days or for 180
         days in any 365 day  period  and (ii) the Board  reasonably  determines
         that  Executive  has been unable to perform  such duties for either 180
         day period  described in Section  3(d)(i)  above as a result of injury,
         illness or other disability.

                  (e)      For Cause by the Company.  The Company may  terminate
         Executive's  employment for "Cause" at any time prior to the expiration
         of the Term  effective  immediately  upon delivery of written notice to
         Executive. For purposes of this Agreement, "Cause" shall mean:

                           (i)      If Executive materially violates any term of
                  this  Agreement  and  such  violation  is  not   substantially
                  remedied  within 30 days of written notice from the Company to
                  Executive;

                           (ii)     Willful  misfeasance,  gross  negligence  or
                  nonfeasance of duty by Executive that is reasonably  likely to
                  be  detrimental or damaging or that has the effect of injuring
                  or damaging the reputation, business or business relationships
                  of the  Company  or any of its  subsidiaries  or any of  their
                  respective officers, directors or employees;

                           (iii)    Any  arrest,   indictment  (defined  as  any
                  proceeding in which "probable cause" is found), conviction (or
                  the civil equivalent) of Executive or a plea of guilty or nolo
                  contendere  by  Executive  to a charge  based on a federal  or
                  state felony or serious criminal or civil offense (even if the
                  crime  is   classified   under   the   applicable   law  as  a
                  "misdemeanor"),  including,  but not  limited to (1) crimes or
                  civil   offenses   involving   theft,   embezzlement,   fraud,
                  dishonesty or moral  turpitude;  (2) crimes or civil  offenses
                  based  on   banking  or   securities   laws   (including   the
                  Sarbanes-Oxley Act of 2002); and (3) civil enforcement actions
                  brought by federal or state regulatory agencies (including the
                  Securities and Exchange Commission).

                           (iv)     Willful or  prolonged  absence  from work by
                  the  Executive  (other  than by reason of legally  protectable
                  disability  due to  physical  or mental  illness)  or failure,
                  neglect or refusal by the  Executive to perform his duties and
                  responsibilities.

                                       3
<PAGE>

                  (f)      Termination  After Change of Control.  Other than for
         voluntary  termination under Section 3(b),  Executive may terminate his
         employment  within six months  after a Change of Control  but only upon
         two weeks prior written notice to the Company.

                  "Change of Control"  shall mean the  occurrence of one or more
         of the following:

                           (i)      any person (as defined in  Sections  3(a)(9)
                  and  13(d)(3)  of the  Securities  Exchange  Act of  1934,  as
                  amended)  other than an existing  stockholder  or an Affiliate
                  that directly or  indirectly  becomes the owner of 50% or more
                  of the Voting Stock;

                           (ii)     a complete liquidation or dissolution of the
                  Company  other than a  liquidation  or  dissolution  occurring
                  after  any  of  the  following  transactions:  the  merger  or
                  consolidation  of the Company with an Affiliate,  the transfer
                  of 50% or  more  of the  Voting  Stock  of the  Company  to an
                  Affiliate or Affiliates  or the sale or other  transfer of all
                  or  substantially  all of the  assets  of  the  Company  to an
                  Affiliate or Affiliates;

                           (iii)    the sale of all or substantially  all of the
                  Company's  assets to a single purchaser or group of affiliated
                  purchasers,  other than any Affiliate or Affiliates, in one or
                  a series of related transactions; or

                           (iv)     the   Company   engages   in  a  merger   or
                  consolidation  with another entity other than an Affiliate and
                  immediately after that merger or consolidation, the persons or
                  entities  that were  stockholders  of the Company  immediately
                  prior  to that  merger  or  consolidation  hold,  directly  or
                  indirectly, less than 50% of the Voting Stock of the surviving
                  entity.

                  "Affiliate" shall mean any corporation,  partnership, trust or
         other entity of which the Company and/or any of its Affiliates directly
         or indirectly owns a majority of the outstanding shares of any class of
         equity security of such corporation, partnership, trust or other entity
         and any corporation,  partnership, trust or other entity which directly
         or indirectly owns a majority of the outstanding shares of any class of
         equity security of the Company or any of its Affiliates.

                  "Voting Stock" shall mean, with respect to a corporation,  the
         capital  stock  of any  class or  classes  of that  corporation  having
         general  voting power under ordinary  circumstances,  in the absence of
         contingencies, to elect directors of such corporation and, with respect
         to any other entity,  the securities of that entity having such general
         voting power to elect the members of the managing body of that entity.

                  (g)      Termination for Good Reason.  Executive may terminate
         his  employment  at any time for "Good  Reason."  For  purposes of this
         Agreement  "Good  Reason"  shall  mean  any  action  on the part of the
         Company not  consented to by Executive in writing  (which  action shall
         not have  been  cured  within 30 days  following  written  notice  from
         Executive to the Board  specifying that such action will give rise to a

                                       4
<PAGE>

         termination of Executive's employment hereunder for Good Reason) having
         the  following  effect  or  effects:   (i)  a  material  diminution  of
         Executive's  job  duties,  responsibilities  or  requirements  that  is
         detrimentally  inconsistent  with the position or  positions  listed in
         Section  1(a)  and  Executive's  prior  duties,   responsibilities   or
         requirements;  (ii) a reduction in  Executive's  salary then in effect,
         other than a reduction comparable to reductions generally applicable to
         similarly  situated  employees  of the  Company;  (iii)  the  permanent
         relocation  of  Executive,  as a result  of a Change of  Control,  to a
         facility  or  location  that is more than 50 miles  from the  Company's
         current  location;  or  (iv) in the  case of a  Change  of  Control,  a
         significant  change in the  reporting  relationship  or title from that
         existing immediately prior to the Change of Control.

                  (h)      Notice of Termination.  Any purported  termination of
         employment shall be communicated  through written notice indicating the
         specific   provision  in  this  Agreement  relied  upon.  In  addition,
         notwithstanding the termination date specified in Executive's notice of
         termination  to the Company  under this  Section 3, the Company may, in
         its sole  discretion,  accelerate the  termination  date to any earlier
         date up to and including the date it received such notice and such date
         shall be considered the termination date.

         4.       Payments.

                  (a)      Generally.   Except  as  provided  below,   upon  the
         termination  of this  Agreement for any reason,  all  compensation  and
         benefits, except benefits provided by law (e.g., COBRA health insurance
         continuation  benefits),  will  immediately  cease to  accrue,  and all
         compensation  and,  except as  otherwise  required by  applicable  law,
         benefits  accrued  through  the  date of  termination  shall be paid to
         Executive in the manner provided below.

                  (b)      Death  or  Disability.   If  the  Company  terminates
         Executive's employment under this Agreement due to death or disability,
         under  Section  3(d) titled  "Disability  or Death,"  Executive  or his
         estate  shall  not be  entitled  to any  further  payments  except  (i)
         Executive's  then current Base Salary  pursuant to Section 2(a) through
         the date of death  and  unreimbursed  expenses  to the date of death as
         provided  herein,  and (ii) any accrued  compensation  and  benefits as
         provided in Section 2.

                  (c)      Voluntary or For Cause.  If Executive  terminates his
         employment  under this  Agreement  without  cause under  Section  3(a),
         titled "Mutual  Agreement",  or if this  Agreement is terminated  under
         Section 3(b), titled "Voluntary," or if this Agreement is terminated by
         the Company  under  Section  3(e)  titled  "For Cause by the  Company,"
         Executive shall not be entitled to any further payments except his then
         current  Base  Salary  pursuant  to Section  2(a)  through  the date of
         termination  and  unreimbursed  expenses to the date of  termination as
         provided herein.

                  (d)      Termination  after Change of Control.  If, within six
         months after a Change of Control,  Executive  terminates his employment
         for Good Reason,  then (i) the Company shall pay to Executive in either
         a lump-sum  or  through  salary  continuation,  at the  Company's  sole
         discretion, the amount of Executive's then current Base Salary pursuant
         to  Section  2(a) for the  balance  of the Term and for a period  of 12
         months  after  expiration  of the Term,  (ii) the Company and the Board

                                       5
<PAGE>

         shall cause all of  Executive's  unvested  stock options to immediately
         vest effective as of the date Executive's  employment  terminates,  and
         Executive  shall have four months to exercise the options  vested under
         this Section 4(d), (iii) if Executive  elects continued  coverage under
         the Company's health plan pursuant to the Comprehensive  Omnibus Budget
         Reconciliation Act of 1985, as amended, then the Company shall continue
         to pay the Company's  portion of the premium for Executive's  continued
         coverage  under the  Company's  health plan until the first to occur of
         (A) the date that is 12 months  after the date of  termination  and (B)
         the date upon  which  Executive  is  employed  by a third  party and is
         eligible for coverage by such third party's  health  insurance plan and
         (iv) if Executive  elects  continued  coverage under the Company's life
         insurance  plan,  then the Company shall  continue to pay the Company's
         portion of the premium for  Executive's  continued  coverage  under the
         Company's  life  insurance  plan,  or if continued  coverage  under the
         Company's life insurance plan is not available pursuant to the terms of
         such plan,  then the Company  shall pay to Executive  the amount of the
         premium that would  otherwise be payable by the Company if  Executive's
         employment were not terminated,  until the date that is 12 months after
         the date of termination. Thereafter, Executive shall not be entitled to
         receive,  and the Company shall have no obligation to provide Executive
         with any additional salary, payments or benefits of any kind.

                  (e)      Without  Cause or for  Good  Reason.  If the  Company
         terminates  Executive's  employment  under Section 3(c) titled "Without
         Cause",  or the  Executive  terminates  for "Good  Reason"  pursuant to
         Section  3(g)(i) or (ii) then (i) the Company shall pay to Executive in
         either a lump-sum or through salary continuation, at the Company's sole
         discretion, the amount of Executive's then current Base Salary pursuant
         to  Section  2(a) for the  balance  of the Term and for a period  of 12
         months after the  expiration  of the Term and (ii) if Executive  elects
         continued  coverage  under the  Company's  health plan  pursuant to the
         Comprehensive  Omnibus Budget  Reconciliation  Act of 1985, as amended,
         then the Company  shall  continue to pay the  Company's  portion of the
         premium for Executive's  continued  coverage under the Company's health
         plan  until the first to occur of (A) the date that is 12 months  after
         the  date of  termination  and (B) the date  upon  which  Executive  is
         employed by a third party and is  eligible  for  coverage by such third
         party's  health  insurance  plan.  Thereafter,  Executive  shall not be
         entitled  to  receive,  and the  Company  shall have no  obligation  to
         provide Executive with any additional  salary,  payments or benefits of
         any kind.

                  (f)      Termination   by   Expiration   Date.  In  the  event
         Executive's   employment  is  terminated  by  the   occurrence  of  the
         Expiration  Date, the Company shall have no obligation to pay Executive
         or provide  Executive  with benefits of any kind beyond the  Expiration
         Date.

                  (g)      Date of Termination.  In each of the foregoing cases,
         termination is the date of actual  termination,  not the date notice of
         termination  is given.  Other than payments  owing under a provision or
         laws  providing  for  payments at a different  time,  all  payments for
         accrued unpaid monthly  compensation shall be made within 10 days after
         the end of the month following the month in which termination  occurred
         and all payments for  reimbursement  shall be made within 45 days after
         the end of the month following the month in which termination occurred.

                                       6
<PAGE>

                  (h)      Release. Executive's eligibility for the benefits set
         forth in Section  4(d) and Section  4(e) is  conditioned  on  Executive
         having first signed a release  agreement in such form as is  reasonably
         satisfactory to the Company.

         5.       Restrictive Covenants.

                  (a)      Nonsolicitation  of Employees.  During the Term,  and
         for a period of one year  thereafter,  Executive  will not  directly or
         indirectly  solicit  or  induce,  or aid any other  entity or person in
         soliciting  or  inducing,  or knowingly  permit any entity  directly or
         indirectly  controlled by him/her to solicit or induce,  any person who
         is, or during the last three months of  Executive's  employment  by the
         Company was, an officer, director, executive, consultant or employee of
         the Company or any of its  affiliates  or any of its existing or future
         subsidiaries  to leave the employment or association  with the Company,
         its  affiliate  or  subsidiary,  to become  employed or retained by any
         other  entity  or to  participate  in the  establishment  of any  other
         business.

                  (b)      Injunction.  Executive agrees that in addition to the
         remedies  the Company may seek and obtain  pursuant to this  Agreement,
         the period during which the non-solicitation covenant contained in this
         Section 5 applies shall be extended by any and all periods during which
         Executive shall be found by a court  possessing  personal  jurisdiction
         over him/her to have been in violation  of the  covenants  contained in
         this Section 5.

         6.       Termination Obligations of Executive.

                  (a)      Return of the Company's  Property.  Executive  hereby
         acknowledges and agrees that all personal property,  including, without
         limitation,  all books, manuals,  records,  reports,  notes, contracts,
         lists,  blueprints,  and  other  documents,  or  materials,  or  copies
         thereof,  and  equipment  furnished  to or prepared by Executive in the
         course of or incident to Executive's employment,  belong to the Company
         and shall be  promptly  returned  to the Company  upon  termination  of
         Executive's employment.

                  (b)      Representations,  Obligations and Warranties  Survive
         Termination  of  Employment.   The  representations,   obligations  and
         warranties  contained in Sections  1(d),  4, 5, 6, 7, 8, 9, 10, 11, 12,
         13,  15,  16 and 17 as well as the terms and  conditions  of  Exhibit A
         shall  survive  the  termination  of  Executive's  employment  with the
         Company.

                  (c)      Cooperation  in  Pending  Work.  Executive  agrees to
         fully cooperate with the Company in all matters relating to the winding
         up of pending work on behalf of the Company and the orderly transfer of
         work to other  employees of the Company  following any  termination  of
         Executive's   employment.   Executive   shall  also  cooperate  in  the
         resolution  of  any  dispute,   including  litigation  of  any  action,
         involving the Company that relates in any way to Executive's activities
         while employed by the Company.

                                       7
<PAGE>

         7.       Confidentiality.

                  (a)      Confidential Information. Executive acknowledges that
         he has had and will have access to certain  information  related to the
         business,  operations,  future plans and customers of the Company,  the
         disclosure or use of which could cause the Company  substantial  losses
         and damages.  Accordingly,  Executive covenants that during the term of
         his   employment   with  the  Company  and   thereafter  he  will  keep
         confidential  all information  and documents  furnished to him by or on
         behalf of the Company and not use the same to his advantage,  except to
         the extent such  information  or documents  are lawfully  obtained from
         other sources on a non-confidential (as to the Company) basis or are in
         public  domain  through  no  fault on his  part or is  consented  to in
         writing by the Company.

                  (b)      Innovations,   Patents,  and  Copyrights.   Executive
         agrees  to  promptly  disclose,  in  writing,  all  Innovations  to the
         Company.  Executive further agrees to provide all assistance  requested
         by the Company, at its expense, in the preservation of its interests in
         any Innovations (as hereinafter defined), and hereby assigns and agrees
         to assign to the Company all rights,  title and  interest in and to all
         worldwide patents, patent applications,  copyrights,  trade secrets and
         other intellectual property rights or "Moral Rights" in any Innovation.
         Furthermore,  during the term of this Agreement,  the Company may, with
         Executive's  written permission (such permission not to be unreasonably
         withheld), use Executive's name and image as appropriate in the conduct
         of its business.

                  "Innovations"  shall  mean  all  developments,   improvements,
         designs, original works of authorship,  formulas,  processes,  software
         programs,  databases,  and trade  secrets,  whether or not  patentable,
         copyrightable  or  protectable  as trade  secrets,  that  Executive  by
         himself  or  jointly  with  others,  creates,  modifies,  develops,  or
         implements during the period of Executive's  employment which relate in
         any way to the  Company's  business.  The term  Innovations  shall  not
         include Innovations  developed entirely on Executive's own time without
         using the Company's  equipment,  supplies,  facilities or  Confidential
         Information,  and which neither relate to the Company's  business,  nor
         result from any work performed by or for the Company.

         8.       Alternative  Dispute  Resolution.  The Company  and  Executive
mutually agree that any  controversy or claim arising out of or relating to this
Agreement  or the breach  thereof,  or any other  dispute  between  the  parties
relating  in  any  way  to  Executive's  employment  with  the  Company  or  the
termination of that  relationship,  including  disputes arising under the common
law  and/or  any  federal  or  state  statutes,  laws or  regulations,  shall be
submitted to mediation before a mutually agreeable mediator, which cost is to be
borne  equally  by the  parties.  In the  event  mediation  is  unsuccessful  in
resolving the claim or controversy,  such claim or controversy shall be resolved
exclusively by  arbitration.  The claims covered by this Agreement  ("Arbitrable
Claims") include, but are not limited to, claims for wages or other compensation
due;  claims for breach of any contract  (including  this Agreement) or covenant
(express or implied); tort claims; claims for discrimination (including, but not
limited to, race, sex, religion,  national origin, age, marital status,  medical
condition, or disability); claims for benefits (except where an employee benefit
or pension  plan  specifies  that its claims  procedure  shall  culminate  in an
arbitration  procedure different from this one); and claims for violation of any
federal, state, or other law, statute,  regulation, or ordinance,  except claims

                                       8
<PAGE>

excluded in the following  paragraph.  The parties  hereby waive any rights they
may have to trial by jury in regard to Arbitrable Claims.

         Claims   Executive   or  the  Company  may  have   regarding   Workers'
Compensation  or  unemployment  compensation  benefits  and the  nonsolicitation
provisions of this  Agreement are not covered by the  arbitration  and mediation
provisions  of this  Agreement.  Claims  Executive  or the  Company may have for
violation of the proprietary information provisions of this Agreement as well as
the terms and  provisions of Exhibit A of this  Agreement are not covered by the
arbitration and mediation provisions of this Section 8.

         Arbitration  under this Agreement shall be the exclusive remedy for all
Arbitrable  Claims.  The Company and Executive agree that  arbitration  shall be
held in Santa Fe, New Mexico and shall be in  accordance  with the  then-current
Employment  Dispute  Resolution Rules of the American  Arbitration  Association,
before an  arbitrator  licensed to practice  law in New Mexico.  The  arbitrator
shall have authority to award or grant both legal,  equitable,  and  declaratory
relief. Such arbitration shall be final and binding on the parties.  The Federal
Arbitration Act shall govern the  interpretation and enforcement of this Section
8 pertaining to Alternative Dispute Resolution.

         This  Agreement  to  mediate  and  arbitrate  survives  termination  of
Executive's employment.

         9.       Notices. All notices and other communications  provided for in
this  Agreement  shall be dated and in writing  and shall be deemed to have been
duly given (a) on the date of delivery, if delivered personally, by e-mail or by
facsimile  machine,  receipt  confirmed,  (b) on the following  business day, if
delivered by a nationally  recognized  overnight  courier service,  with receipt
acknowledgement  requested, or (c) three business days after mailing, if sent by
registered or certified mail, return receipt requested, postage prepaid, in each
case, to the party to whom it is directed at the  following  address (or at such
other address as any party hereto shall  hereafter  specify by notice in writing
to the other parties hereto):

                 CytoDyn, Inc.
                 200 W. DeVargas Street, Suite 1
                 Santa Fe, New Mexico 87501
                 Attn:  Chief Financial Officer
                 Telephone:        (505) 988-5520
                 Facsimile:        (505) 988-5520

and to Executive at:
                 Corinne Allen
                 24 W. Sunlit Drive
                 Santa Fe, NM 87508
                 Telephone:        (505) 988-5520

                                       9
<PAGE>

         10.      Entire Agreement.  The terms of this Agreement,  together with
Exhibit A to this  Agreement,  are  intended  by the parties to be the final and
exclusive  expression  of their  agreement  with  respect to the  employment  of
Executive by the Company and may not be contradicted by evidence of any prior or
contemporaneous  statements or agreements.  The parties further intend that this
Agreement shall constitute the complete and exclusive statement of its terms and
that  no  extrinsic  evidence  whatsoever  may be  introduced  in any  judicial,
administrative, or other legal proceeding involving this Agreement.

         11.      Amendments,  Waivers.  This  Agreement  may  not be  modified,
amended,  or terminated except by an instrument in writing,  signed by Executive
and by a duly authorized  representative of the Company other than Executive. No
failure to exercise and no delay in exercising any right, remedy, or power under
this  Agreement  shall  operate  as a waiver  thereof,  nor shall any  single or
partial exercise of any right,  remedy,  or power under this Agreement  preclude
any other or further  exercise  thereof,  or the  exercise  of any other  right,
remedy, or power provided herein or by law or in equity.

         12.      Assignment;  Successors  and  Assigns.  Executive  agrees that
Executive will not assign,  sell,  transfer,  delegate or otherwise  dispose of,
whether  voluntarily  or  involuntarily,  or by  operation of law, any rights or
obligations  under this Agreement,  nor shall  Executive's  rights be subject to
encumbrance or the claims of creditors.  Any purported assignment,  transfer, or
delegation  shall be null and void.  Subject to the  foregoing,  this  Agreement
shall be binding upon  Executive  and the Company and shall inure to the benefit
of the parties and their respective heirs,  legal  representatives,  successors,
and  permitted  assigns,  and shall not benefit any person or entity  other than
those enumerated above.

         13.      Use of Employee's  Likeness.  Executive authorizes the Company
to use, reuse and to reasonably  grant others the right to use and reuse without
additional  compensation,  Executive's  name,  photograph,  likeness  (including
caricature),   voice  and  biographical  information  and  any  reproduction  or
simulation  thereof  in any media now known or  hereafter  developed,  for valid
business purposes of the Company.

         14.      Exclusion  of Property  of Others.  Executive  covenants  that
he/she has not and will not bring to the  Company or use in the  performance  of
his  duties  any  documents  or  materials  of a  former  employer  that are not
generally  available to the public or that have not been legally  transferred to
the Company.

         15.      Executive's   Authorization   to  Deduct  Amounts  Owed.  Upon
Executive's separation from employment, the Company is authorized to deduct from
Executive's  final wages or other monies due Executive any debts or amounts owed
to the Company by Executive.

         16.      Severability; Enforcement. If any provision of this Agreement,
or the application thereof to any person, place, or circumstance,  shall be held
by a court or arbitrator of competent jurisdiction to be invalid, unenforceable,
or void, the remainder of this Agreement and such provisions as applied to other
persons, places, and circumstances shall remain in full force and effect.

         17.      Governing Law. The validity,  interpretation,  enforceability,
and  performance  of this  Agreement  shall  be  governed  by and  construed  in
accordance with the laws of the United States and the Federal Arbitration Act to
the extent applicable, and otherwise by the laws of the State of New Mexico.

                                       10
<PAGE>

         18.      Executive  Acknowledgment.  The parties  acknowledge  (a) that
they have consulted with or have had the opportunity to consult with independent
counsel of their own choice  concerning this  Agreement,  and (b) that they have
read and understand the Agreement, are fully aware of its legal effect, and have
entered   into  it  freely   based  on  their  own   judgment  and  not  on  any
representations or promises other than those contained in this Agreement.

         19.      Counterparts.  This  Agreement  may be executed in two or more
counterparts,  each of  which  shall be  deemed  an  original,  but all of which
together  shall  constitute  one and the  same  instrument.  Signatures  to this
Agreement may be transmitted via facsimile and such  signatures  shall be deemed
to be originals.

                                       11
<PAGE>

         IN WITNESS WHEREOF, the parties have duly executed this Agreement as of
the date first written above.

Company                                                      Executive

______________________________                  ______________________________
Name:_________________________                  Name:_________________________
Title:________________________

                                       12
<PAGE>

                                    EXHIBIT A

                PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT

                                      A-1J.P. TURNER & COMPANY, LLC
INVESTMENT BANKING
                                        November 25, 2003 (the "Effective Date")
                                                                --------------

Mr. Allen D. Allen
Chief Executive Officer
CytoDyn, Inc.
4236 Longridge Avenue, Suite 302
Studio City, CA 91604

Re:   Financial Representative Agreement with J.P. Turner & Company, LLC

Dear Mr. Allen,

      This letter (the  "Agreement") is to confirm the engagement of J.P. Turner
& Company, LLC (the "Agent") by CytoDyn, Inc, (the "Company") on the above date,
for purposes of providing  services as detailed herein in consideration  for the
fees and compensation described below.

1.0   THE PARTIES

      1.1   The Company,  with its principal  office at 4236  Longridge  Avenue,
Suite 302, Studio City, CA 91604, USA, Phone: 505-988-5520 and Fax: 323-525-0870

      1.2   Agent,  a Georgia  limited  liability  company,  with its  principal
office at 3060 Peachtree  Road,  11th Floor,  Atlanta,  GA, USA,  30305;  Phone:
404-479-8300 and-Fax: 877-660-9935.

      1.3   The persons  executing this  Agreement  represent to each other that
they have full and complete authority to do so.

2.0   THE AGREEMENT

      2.1   The Company desires to consider selling securities (the "Offering").
The Offering shall be on terms and conditions  satisfactory to the Company. As a
result of an  introduction  made  through  Agent to an investor,  either  single
investor,  several investors, or a related entity (collectively the "Investor"),
should al1 or any part of the Offering be placed with the Investor,  the Company
shall owe Agent the fees  described  herein.  Should  the  Company  close on any
introduced  transactions  under this Agreement,  it shall be understood that the
Offering met terms and conditions satisfactory to the Company.

      2.2   It is  acknowledged  by the Company  that it has relied upon its own
advisors in evaluating all aspects of this Offering. The Company represents that
is has not relied upon any  representations  or statements  made by Agent or its
employees  concerning  this  Offering.  Furthermore,  the Company  intentionally
waives  and  releases  Agent from any and all claims or causes of action for any
losses or damages that the Company may sustain as a result of entering into this
Offering.

      2.3   The terms of this  Agreement  shall be 12 months from the  Effective
Date (the "Term"). Upon expiration of this Agreement, Agent shall be entitled to
receive all  accrued  compensation,  including  any unpaid Cash Fees (as defined
below), Warrants (as defined below), an un-reimbursed expenses, if any.

          3060 PEACHTREE ROAD, FLOOR 1100, ATLANTA, GEORGIA, 30305 USA
                      PHONE: 404-479-8300 FAX: 877-660-9935

<PAGE>

      2.4   The Company  shall be under no  obligation  to pay any fees or other
monies  whatsoever  to Agent  unless the purchase of all or part of the Offering
contemplated by this Agreement has closed with the Investor (the "Closing").  If
the Offering is concluded through multiple fundings or stepped milestones,  then
each  separate  funding  shall be deemed a Closing and the fees shall be paid to
Agent at each Closing as described.  The total amount of the fee due Agent shall
be due and  payable on the date of Closing  and  delivered  simultaneous  to the
Agent with the delivery of the funds to the Company.  The Company shall be under
no obligation to consummate any such  Offering,  except upon such terns as shall
be acceptable to the Company in its sole discretion.

      2.5   The Company  represents  and warrants to the Agent that with respect
to the  Offering:  (i) the Company has  consulted  its own legal  counsel on all
aspects  of the  Offering;  (ii) Agent has not made any  representations  to the
Company to induce it to execute this Agreement other than expressly and directly
made herein; (iii) the Company has performed its own due diligence investigation
and had the opportunity to ask questions of the Investor and its management team
and analyze their responses; (iv) the Company has not relied on any information,
representations  or warranties of any  individual or entity,  including  without
limitation  the  Agent,  in  connection  with the  Offering  but for those  made
directly,  personally and epressly by the Investor in the definitive transaction
documents  memorializing  the Offering;  and (v) the Company  acknowledges  that
Agent has acted solely as a finder and introduced the Company to the Investor.

      2.6   Prior to introduction to any particular  Investor,  Agent will first
disclose the identity of the proposed Investor to the Company.  The Company,  at
its sole  discretion,  can approve or decline whether such  introduction  can be
made to the proposed  Investor.  If the Company does not  disapprove  in writing
whether  such an  introduction  can be made to  Investor  within 48 hours of the
disclosure of an Investor by Agent to the Company,  then such inaction  shall be
deemed an  approval.  It is  expressly  agreed that the Company  shall  promptly
respond to all such introduction  proposals.  If approved, any proposed Investor
shall  be  deemed  a  proposed   investor  (the  "Agent   Proposed   Investor").
Compensation,  shall be triggered if an Agent's  Proposed  Investor,  or parties
referred  by an  Agent's  Proposed  Investor,  invest  during  the  Term  of the
Agreement,  as amended,  plus 180 days.  If the  Company in its sole  discretion
agrees to a term sheet provided by Agent via one of Agent's  Proposed  Investors
by mutually  executing  the said term sheet,  the Company  will grant to Agent a
30-day exclusive period from the date at which the term sheet was consummated.

3.0   THE FEE

      3.1   The  Company  shall pay Agent  cash fee equal to 10.00% of the gross
proceeds of the  Offering  (the "Cash  Fee"} as  received  by the  Company  from
Agent's Proposed Investors.  The Company shall also issue the Agent a warrant to
purchase a number of the  Company's  common  shared  equal to 7.00% of the gross
proceeds of the Offering (the "Warrant") as received by the Company from Agent's
Proposed  Investors.  The  Warrant  shall have an  exercise  price  equal to the
closing bid price of the  Company's  common  shares on the prior trading date to
the Closing (the "Strike Price").

      3.2   In further  consideration  for the services  described  herein,  the
Company shall issue and deliver to Agent a non-refundable  common stock purchase
warrant (the "Investment Warrant" collectively with the Warrant, the "Warrants")
for the purchase of three  hundred  thousand  (300,000)  shares of the Company's
common stock.  The  Investment  Banking  Warrant shall have an exercise price of
thirty tents ($.30) per share upon issuance, be fully paid, non-assessable,  and
free of any restrictions on transfer,  but for those  restrictions  that are the
result of state or federal  securities law. The Investment Banking Warrant shall
immediately and completely vest in favor of the Agent.

            The Warrants upon issuance,  shall  immediately vest in favor of the
Agent, be fully paid, non-assessable,  and free of any restrictions on transfer,
but for those restrictions that are the result of state or

          3060 PEACHTREE ROAD, FLOOR 1100, ATLANTA, GEORGIA, 30305 USA
                      PHONE: 404-479-8300 FAX: 877-660-9935

<PAGE>

federal  securities laws. The Warrants shall be issued to Agent in the form of a
a warrant  agreement  (the  "Warrant  Agreement"),  which shall be in a form and
content reasonably  satisfactory to Agent and its counsel. The Warrant Agreement
shall provide for,  among other  provisions,  the above terms and the following:
(1) The  Warrants  shall  expire  five  years  after the date  that the  Warrant
Agreement  is  issued  (2)  The  Warrants  shall  have  customary  anti-dilution
provisions for stock dividends,  splits,  mergers, and sale of substantially all
assets of the  Company  (3) Agent may  exercise  the  Warrants at any time after
signing  the  Warrant  Agreement  (4) The  Warrants  shall  contain a  "Cashless
Exercise"  provision  (5) The  Company  shall  reserve,  and at all  times  have
available,  a sufficient  number of shares of its common stock to be issued upon
the exercise of the Warrants and (6) The Company  shall grant  unlimited  "piggy
back" registration  rights, at the Company's  expense,  to include the shares of
the underlying  common stock in any registration  statement filed by the Company
under the  Securities  Act of 1933  relating to an  underwriting  of the sale of
shares of common stock or other security of the Company.

4.0   OTHER

      4.1   Any  arrangements  made by the  Company  with  any  broker  or other
persons with whom the Company is or may be involved are the total responsibility
of the Company.  Upon payment made by the Company to Agent of Agent's fee, Agent
will hold the Company  free and harmless  from any and all claims,  liabilities,
commissions, fees, or expenses in connection with the transaction from any party
who alleges a relationship with or through Agent and the Investors.

      4.2   The Company  shall also prepay or reimburse  Agent for all necessary
expenses which are preapproved by the Company,  including,  without  limitation,
acceptable travel and lodging, printing, legal, and mailing cost, that Agent may
incur in performance of the Services under this Agreement.

      4.3   The Company shall supply to Agent, logos,  trademarks,  slogans, and
similar designs of itself and all subsidiaries  and agrees to Agent's  perpetual
use thereafter in "Tombstones" that reflect the Agent's fundraising efforts.

      4.4   Either the Company or the Agent can terminate this Agreement for any
reason by  providing  not less than 45 days  prior  written  notice to the other
party.

      4.5   In the event of any dispute  between  the Company and Agent  arising
under or pursuant to the terms of this  Agreement,  or any matters arising under
the terms of this  Agreement,  the same  shall be  settled  only by  arbitration
through NASD Dispute Resolution in Fulton City of Atlanta,  State of Georgia, in
accordance  with the Code of  Arbitration  Procedure  published  by NASD Dispute
Resolution. The determination of the arbitrators shall be final and binding upon
the  Company  and  Agent  and  may be  enforced  in  any  court  of  appropriate
jurisdiction.  This  Agreement  shall be construed  by and governed  exclusively
under the laws of the State of Georgia,  without  regard to its conflicts of law
provisions. The venue shall be in Fulton County, GA

      4.6   This Agreement  contains the entire agreement  between Agent and the
Company  concerning the  introduction  of Investors to the Company and correctly
sets forth the rights and duties of each of the parties to each other concerning
that matter as of this date.  Any  agreement or  representation  concerning  the
subject  matter  of this  Agreement  or the  duties of Agent to the  Company  in
relation thereto, not set forth in this Agreement, is null and void.

      4.7   The  Company  agrees  that upon the  Closing  the Agent will be paid
simultaneously  with the funding of the Company from the  Offering.  The Company
shall  include  in any  agreement  executed  by the  Company  with any  Investor
regarding the Offering a covenant  requiring Agent to be paid its fees hereunder
either from the funds held in escrow  pending  the Closing or directly  from the
Investors in accordance with the following wiring instructions:

          3060 PEACHTREE ROAD, FLOOR 1100, ATLANTA, GEORGIA, 30305 USA
                      PHONE: 404-479-8300 FAX: 877-660-9935

<PAGE>

            Account Name:          J.P. Turner & Company, L.L.C.
            Bank:                  Wachovia Bank of Georgia
            Address:               4465 Buckhead Loop, Atlanta, GA 30326
            Phone:                 404-995-8740
            Fax:                   404-995-8755
            ABA Routing #:         061-000-010
            Account #:             186-834-16

            The Warrant shall be assigned to J.P. Turner & Company,  L.L.C.  and
emailed or mailed to the following address:

            power@jpturner.com
            ------------------

                    or

            J.P. Turner & Company, L.L.C.
            Attention: Patrick J. Power, Managing Director of Investment Banking
            3036 Peachtree Road, 11th Floor
            Atlanta, GA 30326
            Phone:404-479-8300
            Fax: 877-660-9935

      4.8   The Company  agrees to indemnify  and hold  harmless  Agent and each
person,  if any, who controls  Agent within the meaning of the Securities Act of
1933,  as  amended  (the  "Act"),  its  officers,   employees,  Agent's  counsel
(collectively,  the "Agent and its  Personnel")  from and  against  any  losses,
claims, damages or liabilities,  joint or several (which shall, for all purposes
of this  Agreement,  include,  but not be limited  to, all  reasonable  costs of
defense,  investigation  and collection and all attorneys' fees), to which Agent
and its Persoonel may become subject,  under the Act or otherwise,  insofar,  as
such losses, claim, damages or liabilities (or actions in respect thereof);  (i)
arising  out of or are  based  upon  any  untrue  statement  or  alleged  untrue
statement  of any  material  fact made by the Company its  officers,  employees,
agents,  and the  legal  counsel;  (ii)  arising  out of or are  based  upon any
omission or alleged  omission of material  fact  necessary to make any statement
not misleading,  made by the Company its officers,  employees,  agents,  and its
legal  counsel,,  (iii) arising in any manner out of or in  connection  with the
performing of services by Agent hereunder; (iv) arising out of or based upon any
violation of the representations and warranties of the Investor; and (v) arising
out of or are based upon any untrue statement or alleged untrue statement of any
material fact made by the Company their  officers,  employees,  agents,  and the
legal counsel.

      4.9   The Company shall  include in any agreement  executed by the Company
with  any  Investor  regarding  the  Offering,  the  following   representation:
"Investor  has  performed  its  own  due  diligence  investigation  and  had the
opportunity to ask questions of the Company and its management  team and analyze
their responses.  Investor has not relied on any representations not made by the
Company and that are not  expressly  set forth in the  purchase  agreement.  The
Company  has  performed  its  own  due  diligence  investigation  and,  had  the
opportunity to ask questions of the Investor and its management team and analyze
their responses.  The Company has not relied on any  representations not made by
the Investor  and that are not  expressly  set forth in the purchase  agreement.
Both parties to the purchase  agreement  shall  release and hold  harmless  J.P.
Turner &  Company,  L.L.C.  from and  against  any  losses,  claims,  damages or
liabilities  related to the Offering.  Furthermore,  both parties recognize that
the Agent only act as a finder and other than  introducing  them,  the Agent had
and will have no further role."

          3060 PEACHTREE ROAD, FLOOR 1100, ATLANTA, GEORGIA, 30305 USA
                      PHONE: 404-479-8300 FAX: 877-660-9935

<PAGE>

      If the foregoing is in accordance with you  understanding,  kindly confirm
your  acceptance by signing and returning the  Agreement,  which will  thereupon
constitute an agreement between us.

                                            Yours very truly,

                                            William Mello
                                            President
                                            J.P. Turner & Company, LLC

Accepted and approved this 7th day of December, 2003
                           ---        --------

By: /s/ Allen D. Allen
   ----------------------
Mr. Allen D. Allen
Chief Executive Officer
CytoDyn, Inc.
4236 Longridge Avenue
Phone: 818-501-8737
       ----------------
Fax:   323-525-0870
       ----------------

          3060 PEACHTREE ROAD, FLOOR 1100, ATLANTA, GEORGIA, 30305 USA
                      PHONE: 404-479-8300 FAX: 877-660-9935

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]